Free Trial
NASDAQ:ABSI

Absci (ABSI) Stock Price, News & Analysis

Absci logo
$2.90 +0.07 (+2.47%)
Closing price 08/1/2025 04:00 PM Eastern
Extended Trading
$2.91 +0.01 (+0.34%)
As of 08/1/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Absci Stock (NASDAQ:ABSI)

Key Stats

Today's Range
$2.74
$2.92
50-Day Range
$2.57
$3.63
52-Week Range
$2.01
$6.33
Volume
4.91 million shs
Average Volume
6.54 million shs
Market Capitalization
$369.92 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$8.28
Consensus Rating
Buy

Company Overview

Absci Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
64th Percentile Overall Score

ABSI MarketRank™: 

Absci scored higher than 64% of companies evaluated by MarketBeat, and ranked 332nd out of 919 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Absci has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 5 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Absci has only been the subject of 2 research reports in the past 90 days.

  • Read more about Absci's stock forecast and price target.
  • Earnings Growth

    Earnings for Absci are expected to grow in the coming year, from ($0.89) to ($0.69) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Absci is -3.15, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Absci is -3.15, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Absci has a P/B Ratio of 1.86. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Absci's valuation and earnings.
  • Percentage of Shares Shorted

    27.86% of the float of Absci has been sold short.
  • Short Interest Ratio / Days to Cover

    Absci has a short interest ratio ("days to cover") of 8.7.
  • Change versus previous month

    Short interest in Absci has recently decreased by 3.24%, indicating that investor sentiment is improving.
  • Dividend Yield

    Absci does not currently pay a dividend.

  • Dividend Growth

    Absci does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    27.86% of the float of Absci has been sold short.
  • Short Interest Ratio / Days to Cover

    Absci has a short interest ratio ("days to cover") of 8.7.
  • Change versus previous month

    Short interest in Absci has recently decreased by 3.24%, indicating that investor sentiment is improving.
  • News Sentiment

    Absci has a news sentiment score of 0.78. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.62 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 13 news articles for Absci this week, compared to 4 articles on an average week.
  • Search Interest

    18 people have searched for ABSI on MarketBeat in the last 30 days. This is an increase of 50% compared to the previous 30 days.
  • MarketBeat Follows

    11 people have added Absci to their MarketBeat watchlist in the last 30 days. This is an increase of 450% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Absci insiders have bought more of their company's stock than they have sold. Specifically, they have bought $152,000.00 in company stock and sold $0.00 in company stock.

  • Percentage Held by Insiders

    10.49% of the stock of Absci is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    52.05% of the stock of Absci is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Absci's insider trading history.
Receive ABSI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Absci and its competitors with MarketBeat's FREE daily newsletter.

ABSI Stock News Headlines

One Absci Insider Raised Stake By 61% In Previous Year
Trump’s national nightmare is here
Porter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger the biggest forced rotation of capital since World War II. They reveal why Trump is mobilizing America’s tech giants… and name the two stocks most likely to soar as trillions shift behind the scenes.
Morgan Stanley Cuts Absci (NASDAQ:ABSI) Price Target to $6.40
See More Headlines

ABSI Stock Analysis - Frequently Asked Questions

Absci's stock was trading at $2.62 on January 1st, 2025. Since then, ABSI shares have increased by 10.7% and is now trading at $2.90.

Absci Corporation (NASDAQ:ABSI) posted its quarterly earnings data on Tuesday, May, 13th. The company reported ($0.21) EPS for the quarter, topping the consensus estimate of ($0.23) by $0.02. The company had revenue of $1.18 million for the quarter, compared to analyst estimates of $1.07 million. Absci had a negative trailing twelve-month return on equity of 53.69% and a negative net margin of 2,232.13%.
Read the conference call transcript
.

Absci (ABSI) raised $200 million in an IPO on Thursday, July 22nd 2021. The company issued 12,500,000 shares at $15.00-$17.00 per share.

Top institutional shareholders of Absci include ARK Investment Management LLC (7.88%), Sumitomo Mitsui Trust Group Inc. (1.15%), IQ EQ FUND MANAGEMENT IRELAND Ltd (0.12%) and DKM Wealth Management Inc. (0.02%). Insiders that own company stock include Phoenix Venture Partners Ii Lp, Redmile Group, Llc, Zachariah Jonasson and Andreas Busch.
View institutional ownership trends
.

Shares of ABSI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Absci investors own include Invesco QQQ (QQQ), NVIDIA (NVDA), Broadcom (AVGO), Meta Platforms (META), Advanced Micro Devices (AMD), Arista Networks (ANET) and CrowdStrike (CRWD).

Company Calendar

Last Earnings
5/13/2025
Today
8/02/2025
Next Earnings (Estimated)
8/13/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Business Services
Current Symbol
NASDAQ:ABSI
CIK
1672688
Fax
N/A
Employees
210
Year Founded
N/A

Price Target and Rating

High Price Target
$10.00
Low Price Target
$6.40
Potential Upside/Downside
+185.5%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
5 Analysts

Profitability

EPS (Trailing Twelve Months)
($0.92)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$103.11 million
Net Margins
-2,232.13%
Pretax Margin
-2,231.01%
Return on Equity
-53.69%
Return on Assets
-45.89%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
5.72
Quick Ratio
5.72

Sales & Book Value

Annual Sales
$4.82 million
Price / Sales
76.83
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.56 per share
Price / Book
1.86

Miscellaneous

Outstanding Shares
127,559,000
Free Float
114,178,000
Market Cap
$369.92 million
Optionable
Optionable
Beta
2.01

Social Links

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (NASDAQ:ABSI) was last updated on 8/2/2025 by MarketBeat.com Staff
From Our Partners